AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18689550
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of diet and exercise (DE)
Trial: 11433088
Drug: CT (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT (Conventional Treatment)
Trial: 11433088
Drug: CTM (Conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CTM (Conventional Treatment with 2 Anorectal Manometry sessions)
Trial: 9609557
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy with glucocorticoids
Trial: 9609557
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy without glucocorticoids
Trial: 8054247
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) 250 mg orally
Trial: 8054247
Drug: Dideoxyinosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dideoxyinosine (ddI) 250 mg orally
Trial: 8054247
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ZDV 250 mg plus ddI 250 mg orally
Trial: 2455426
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil lotion (2% and 5%)
Trial: 2455426
Drug: Placebo minoxidil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo minoxidil lotion
Trial: 28772041
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM) therapy
Trial: 10847236
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of two risk factors
Trial: 10847236
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of three risk factors
Trial: 27809848
Drug: Conventional anti-diabetic
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anti-diabetic agents
Trial: 31159796
Drug: Well-being therapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Well-being therapy (WBT) for 5 weeks, n=39
Trial: 31159796
Drug: Placebo control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo control condition (CC) for 5 weeks, n=48
Trial: 25881796
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (single dose)
Trial: 24680087
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) - intravenous 1 g bolus, 1 g infusion/8 h
Trial: 22001815
Drug: Rinsing with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rinsing with 2 ml of balanced saline solution
Trial: 19155004
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus cyclic medroxyprogesterone acetate (MPA) 5 mg twice a day
Trial: 17519068
Drug: bimatoprost/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bimatoprost/timolol fixed combination (BTFC)
Trial: 17519068
Drug: latanoprost/timolol fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: latanoprost/timolol fixed combination (LTFC)
Trial: 9094726
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of nebulized ipratropium added to three albuterol nebulizations administered over 1 hour
Trial: 9094726
Drug: 0 doses
RxNorm normalized name: mometasone furoate 220 mcg/actuation (30 doses) INHALATION AEROSOL POWDER, BREATH ACTIVATED (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 doses of nebulized ipratropium added to three albuterol nebulizations administered over 1 hour
Trial: 7682029
Drug: Risperidone 4-12
RxNorm normalized name: risperidone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 4-12 mg
Trial: 30425014
Drug: Buzzy (thermomechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buzzy (thermomechanical stimulation) during injection
Trial: 27634091
Drug: Connective tissue
RxNorm normalized name: Connective tissue protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Connective tissue manipulation (CTM) twice per week for 6 weeks
Trial: 27634091
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (CG)
Trial: 23875818
Drug: Prophylactic single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic single-dose antibiotic administered preoperatively
Trial: 23875818
Drug: Prophylactic single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic single-dose antibiotic administered at cord clamping
Trial: 20921085
Drug: Atorvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (20 mg/day) 3 weeks before surgery
Trial: 20921085
Drug: Methylprednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (10 mg/kg, single shot)
Trial: 14620117
Drug: MTX microtextured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX microtextured implant surfaces
Trial: 14620117
Drug: Machined implant
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Machined implant surfaces
Trial: 10928438
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% caudally (0.5 mL kg(‐1))
Trial: 10928438
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Clonidine (1 microg kg(‐1))
Trial: 10928438
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Sufentanil (0.5 microg kg(‐1))
Trial: 10928438
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% caudally (0.5 mL kg(‐1)) + Clonidine (0.5 microg kg(‐1)) + Sufentanil (0.25 microg kg(‐1))
Trial: 8909667
Drug: Inhaled aerosolized
RxNorm normalized name: Albuterol Inhalation Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled aerosolized prostacyclin 50 ng/kg/min
Trial: 28841847
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who are activated (e.g., ask questions, express opinions, ask for clarification)
Trial: 24460069
Drug: Daily walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily walking intervention (10,000 steps per day and a weekly supervised group walk) for 10 weeks
Trial: 24460069
Drug: Daily walking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily walking intervention
Trial: 19709327
Drug: Aqueous leaf
RxNorm normalized name: Belladonna Leaf
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous leaf extracts of Syzygium cumini (ASC) at 60-1000 microg/mL
Trial: 12377799
Drug: 2.5 micro
RxNorm normalized name: Digoxin 62.5 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 micro g LT
Trial: 12377799
Drug: 0.5 micro
RxNorm normalized name: calcitriol 0.5 MICROGRAM In 1 CAPSULE ORAL CAPSULE, LIQUID FILLED [Rocaltrol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 micro g LT
Trial: 12377799
Drug: 0.1 micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 micro g LT
Trial: 10199429
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens, 1.25 mg/d for 21 days
Trial: 7754476
Drug: Homeopathic treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic treatments (various drugs prescribed by homeopathic physicians)
Trial: 30303664
Drug: Dalargin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalargin therapy (2 mg/day for 10 days, 3 courses during 3 months)
Trial: 19514183
Drug: needle‐rolling therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: needle‐rolling therapy
Trial: 16772810
Drug: Olanzapine 5
RxNorm normalized name: olanzapine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 5 mg/d (increased to mean 10.55 mg/d)
Trial: 16772810
Drug: Olanzapine 20
RxNorm normalized name: olanzapine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 20 mg/d (fixed dose)
Trial: 15618849
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy during colonoscopy
Trial: 11819728
Drug: Hepatic artery
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatic artery ligation (HAL) and/or hepatic artery infusion (HAI) (Group B)
Trial: 11819728
Drug: Transcatheter hepatic
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter hepatic arterial chemoembolization (TACE) or HAI and/or portal vein infusion (PVI) after operation (Group D)
Trial: 9247243
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (blast type)
Trial: 7509784
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Trasylol (Hammersmith dosage: 6 x 10(6) KIU)
Trial: 7509784
Drug: Low Dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Dose Trasylol (half of Hammersmith dosage)
Trial: 7509784
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Trasylol
Trial: 7509784
Drug: Low Dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Dose Trasylol
Trial: 7509784
Drug: High Dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Dose Trasylol and Low Dose Trasylol
Trial: 2959236
Drug: Captopril (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (average dosage 265 mg/d, range 150-300 mg)
Trial: 2959236
Drug: Minoxidil (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minoxidil (average dosage 19.6 mg/d, range 7.5-30 mg)
Trial: 31948461
Drug: Aspirin (n
RxNorm normalized name: ACETAMINOPHEN 250 mg / ASPIRIN 250 mg / CAFFEINE 65 mg ORAL TABLET, FILM COATED [EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (n = 40)
Trial: 23533254
Drug: Intrathecal clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal clonidine (0-100 µg)
Trial: 23533254
Drug: Intrathecal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal bupivacaine (0-8.8 mg)
Trial: 20592725
Drug: Ferumoxytol (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol (two 510 mg doses administered 24 h apart)
Trial: 16841666
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and multi-glycosides of tripterygii (MT)
Trial: 8545138
Drug: Methadone (custom-made
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (custom-made capsules)
Trial: 8545138
Drug: Methadone (suppositories)
DrugBank: Methadone (DB00333)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methadone (suppositories)
Trial: 1902052
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin (ECA) 325 mg
Trial: 18760125
Drug: Patient self-management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient self-management (SM) skills training in combination with HF education
Trial: 15973062
Drug: Oral ramosetron
RxNorm normalized name: alosetron Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ramosetron
Trial: 15973062
Drug: Dopamine D2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine D2 receptor-blocker (historical control)
Trial: 12204841
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with saquinavir soft gel, zalcitabine and zidovudine for 52 weeks
Trial: 12204841
Drug: Baseline viral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline viral load and development of genotypic mutations on therapy
Trial: 12204841
Drug: Plasma saquinavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma saquinavir concentration < 50 mg/ml at 4 weeks
Trial: 8803522
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg orally
Trial: 8803522
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg orally
Trial: 8803522
Drug: Lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 15 mg intravenously
Trial: 1618070
Drug: Cisapride (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (2.5 mg and 5 mg)
Trial: 6705640
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg sublingually/buccally)
Trial: 6705640
Drug: Propantheline bromide
RxNorm normalized name: Propantheline Bromide
DrugBank: Propantheline (DB00782)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propantheline bromide (15 mg orally)
Trial: 6705640
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nifedipine and propantheline bromide
Trial: 26908401
Drug: Edoxaban (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (high-dose edoxaban regimen - 60 mg daily; lower-dose edoxaban regimen - 30 mg daily) with SAPT (aspirin 92.5%)
Trial: 26908401
Drug: Edoxaban (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (high-dose edoxaban regimen)
Trial: 26908401
Drug: Edoxaban (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (high-dose edoxaban regimen) with SAPT
Trial: 26908401
Drug: Warfarin without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin without SAPT
Trial: 26908401
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with SAPT
Trial: 26908401
Drug: Edoxaban (lower-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (lower-dose edoxaban regimen) without SAPT
Trial: 26908401
Drug: Edoxaban (lower-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (lower-dose edoxaban regimen) with SAPT
Trial: 25089537
Drug: Weekly oral
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly oral dose of 0.875 mg vitamin D₃ (vitD₃)
Trial: 18545061
Drug: 120 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg/day of extract of ginkgo biloba (EGb) for 12 weeks
Trial: 8701398
Drug: Hirudin (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (10, 15 or 20 mg s.c. b.i.d.)
Trial: 8701398
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5000 IU s.c. t.i.d.)
Trial: 1649267
Drug: Chemotherapy (CE'P
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CE'P and MEC' regimens)
Trial: 6378303
Drug: Clorgyline (monoamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clorgyline (monoamine oxidase inhibitor)
Trial: 30777471
Drug: Resveratrol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol (400 mg) for 12-14 weeks
Trial: 21725047
Drug: Nonmyeloablative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonmyeloablative chemotherapy
Trial: 18290397
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous deferoxamine (130 mg/kg per day over 10-14 hours for 5 consecutive days)
Trial: 18290397
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous deferoxamine
Trial: 15471837
Drug: 99mTc‐pertechnetate per‐rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 99mTc‐pertechnetate per‐rectal portal scintigraphy (PPS)
Trial: 11387540
Drug: Self-help kit
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-help kit and fully covered benefits for OTC nicotine replacement therapy (NRT) gum and patch, and participation in a group behavioural cessation programme with no patient cost sharing
Trial: 9263614
Drug: Ipriflavone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipriflavone (3 x 200 mg/day)
Trial: 8280818
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg omeprazole once daily (second 4 weeks)
Trial: 8280818
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole once daily (second 4 weeks)
Trial: 8280818
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole (4 weeks) then 20 mg (second 4 weeks)
Trial: 8280818
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole (4 weeks) then 40 mg (second 4 weeks)
Trial: 30644785
Drug: CHO group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO group (800 ml the evening before and 400 ml 2 hours before anesthesia)
Trial: 26380366
Drug: Psychoeducational program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducational program (12 weekly 1.5-hour sessions)
Trial: 23412645
Drug: Learning Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Learning Therapy (cognitive intervention program)
Trial: 17324377
Drug: Tooth preparation
RxNorm normalized name: porcine tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth preparation for full crown and application of one‐step self‐etch adhesive (iBond Gluma inside)
Trial: 9835498
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (3 microgram/kg/min)
Trial: 8528892
Drug: Spironolactone (type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (type I glucocorticoid receptor antagonist), administered in increasing doses, orally.
Trial: 8528892
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered orally.
Trial: 2909317
Drug: 0.1 mg/kg.h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg.h
Trial: 2909317
Drug: 0.2 mg/kg.h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg.h
Trial: 30099833
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid solution (Transamin inj/sol 500 mg/5 mL) infused wet dressing for 20 minutes
Trial: 30099833
Drug: Microneedling with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microneedling with tranexamic acid solution topical application followed by tranexamic acid solution infused dressing therapy every 15 days for four sessions
Trial: 23477572
Drug: Androgen deprivation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen deprivation therapy and radiation therapy (ADT‐RTH)
Trial: 23477572
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy only (RTH)
Trial: 21684281
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg LX1031, given 4 times/day
Trial: 21684281
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg LX1031, given 4 times/day
Trial: 11295717
Drug: RORS-G (glucose-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RORS-G (glucose-based reduced osmolarity ORS)
Trial: 9229021
Drug: Ivermectin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (150 micrograms/kg body weight) on day 1 followed by amocarzine (3 mg/kg twice daily after meals) on days 8, 9, and 10
Trial: 23449426
Drug: Allopurinol 600
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol 600 mg/day for 9 months
Trial: 16818810
Drug: Beta-blocker therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker therapy (control group)
Trial: 12507797
Drug: Mandatory drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandatory drug testing (DT)